Xiaoyan Ying

Xiaoyan Ying


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2020 in Cell Cycle
Verified
Journal Article
Closed access
YHYun Han
Yun Han
CSChao Song
Chao Song
TZTingting Zhang
Tingting Zhang
QZQianqian Zhou
Qianqian Zhou
XZXiaoqian Zhang
Xiaoqian Zhang
XYXiaoyan Ying
Xiaoyan Ying
Wilms’ tumor 1 (WT1) is reported to play an important role in tumor invasion and metastasis, two hallmarks of ovarian cancer (OC) that influence treatment efficacy and prognosis. However, the specific roles and underlying mechanisms of WT1 in OC have not been fully understood. Here, we investigated the potential function and signaling pathways of WT1 in OC cells. We showed that WT1 was significantly upregulated in human OC tissues and closely associated with OC type, grade and FIGO stage. In cultured cells and xenograft mouse models, WT1 depletion significantly inhibited cell migration and invasion, reversed epithelial–mesenchymal transition (EMT), and prevented metastasis of OC cells. We further demonstrated that WT1 inhibited E-cadherin expression via targeting E-cadherin gene promoter by chromatin immunoprecipitation and luciferase reporter assay. Moreover, ERK1/2 activation was suppressed upon WT1 silencing. Inhibiting ERK1/2 phosphorylation increased E-cadherin expression and suppressed WT1-induced OC cell migration and invasion. Taken together, our study reveals WT1 exerts a tumor-promoting role in OC, enhancing EMT through negative modulation of E-cadherin expression via ERK1/2 signaling. WT1 may represent a novel therapeutic target that may improve the prognosis of OC.

25 May 2021 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
MZMiaomiao Zhu
Miaomiao Zhu
CYChenxia Ye
Chenxia Ye
JWJing Wang
Jing Wang
GYGuangxia Yang
Guangxia Yang
XYXiaoyan Ying
Xiaoyan Ying
Although radiotherapy is a common treatment option for all kinds of cancer patients, including ovarian cancer, a major obstacle limiting its application in the development of resistance. Therefore,...

4 August 2022 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
MYMinmin Yu
Minmin Yu
SXSonglin Xue
Songlin Xue
XCXin Chen
Xin Chen
KWKaihua Wu
Kaihua Wu
LJLili Ju
Lili Ju
XYXiaoyan Ying
Xiaoyan Ying

1 May 2020 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
HQHaifeng Qiao
Haifeng Qiao
JLJinwei Liu
Jinwei Liu
ZYZhixia Yang
Zhixia Yang
LGLeilei Gao
Leilei Gao
XZXiaolan Zhang
Xiaolan Zhang
DZDong Zhang
Dong Zhang
Background: Ovarian cancer is a severe gynecological malignancy. Paraneoplastic Ma antigen 5 (PNMA5) is a confirmed tumor onconeural antigen, which has been screened as a female fertility factor. PNMA5 overexpression might serve as a marker of poor prognosis in colon cancer. Our earlier study showed that PNMA5 was essential for meiosis in mouse oocytes. In this study, we investigate the role and probable mechanism of PNMA5 in the occurrence and development of epithelial ovarian cancer (EOC). Methods: Immunochemistry and western blot analyses were used to verify PNMA5 overexpression in clinical EOC tissues and EOC cell line HO8910. A specific siRNA was used to reduce PNMA5 levels, and several proliferation and migration-related indexes were assessed. We also examined mitochondria, microfilaments, and several essential kinases. Results: We found that the expression of PNMA5 in EOC tissues was significantly higher than that in benign ovarian tumors and healthy normal ovarian tissues and that this was strictly related to the FIGO stage and histological grade. PNMA5 expression in ovarian cancer cell line HO8910 was higher than that in the normal healthy ovarian cell line Moody. PNMA5 knockdown in HO8910 cells not only inhibited the proliferation, migration, invasion, cell cycle, and F-actin polymerization of HO8910 cells but also promoted early apoptosis and led to abnormal distribution and accumulation of mitochondria. PNMA5 phosphorylation was found to be positively regulated by Src activity, and PNMA5 phosphorylation promoted the downstream glycogen synthase kinase-3β (GSK-3β) signaling pathway. Conclusions: PNMA5 plays a pivotal role in the occurrence and development of EOC and is a potential marker of this disease.

16 July 2022 in Journal of Biomedical Research
Verified
Journal Article
Open access
PDF file
XHXiangdong Hua
Xiangdong Hua
YZYan Zhang
Yan Zhang
JXJuan Xu
Juan Xu
LXLu Xu
Lu Xu
YSYaqian Shi
Yaqian Shi
XYXiaoyan Ying
Xiaoyan Ying
Intrauterine adhesion (IUA) is a common clinical endometrial disease, which can severely damage the fertility and quality of life in women. This study aims to find the differentially expressed endogenous peptides and their possible roles in IUA. Liquid chromatography-mass spectrometry was used to identify the peptidomic profiling of IUA tissues, and the differentially expressed peptides were screened out. Using real-time quantitative PCR, Western blotting, and immunocytochemistry staining, the function of six endogenous peptides was verified in vitro. It was found that peptide 6 (T6) (peptide sequence: TFGGAPGFPLGSPLSSVFPR) could inhibit the expression of TGF-β1-induced cell fibrosis in human endometrial stromal cell line and primary human endometrial stromal cell at a concentration of 50 μmol/L. This study provides new targets for further clarifying the formation and prevention of IUA.

14 October 2024 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
LYLi-Li Yang
Li-Li Yang
XZXue-Ke Zhang
Xue-Ke Zhang
YCYing Cao
Ying Cao
LSLi-Ya Shi
Li-Ya Shi
SXShi-Ya Xie
Shi-Ya Xie
XYXiaoyan Ying
Xiaoyan Ying